Semiconductor company Qualcomm Inc. escalated its riff with handset maker Nokia Corp. on Monday, asking the U.S. International Trade Commission to investigate its allegations of patent infringement against Nokia.
The United States may bring a World Trade Organization case against China because officials are failing to live up to their promises to stop intellectual property infringement, a top U.S. official said this week.
Hoping to boost the firm’s East Coast intellectual property practice, Perkins Coie has plucked two patent veterans from the ranks of Morrison & Foerster and WilmerHale LLP to join its Washington, D.C. office.
The International Trade Commission plans to investigate whether drug maker Sanofi-Aventis violated patent laws in what has turned into a bittersweet struggle over an insulin delivery system patent between the French company and Danish drug maker Novo Nordisk A/S.
With a second countersuit, Apple Computer Inc. has widened the patent battle triggered by rival Creative Technology Ltd., accusing the company of infringing additional patents for its iPod digital music player.
In a move that may thwart Chinese knock-offs of the popular anti-erectile dysfunction drug Viagra, a Beijing court has ruled that China’s patent review board erred when it invalidated Pfizer Inc.’s patent, marking the latest turn in the country’s attempts to quell pharmaceutical piracy.
World Trade Organization Chief Pascal Lamy warned trade ministers Tuesday that they need to wrap up a deal meant to reduce farm subsidies and tariffs on farm and industrial goods, setting a deadline for the end of June.
Amid growing criticism that poor nations are being denied access to crucial medicines, vaccines and diagnostic tests, the World Health Organization said it plans to review whether the international drug patent system curbs the ability of developing countries to obtain patented medical treatments.
Vermont Sen. Patrick Leahy introduced a compulsory patent licensing bill to the Senate on Thursday that would enable U.S. generic drug firms to make low-cost generic versions of patented medicines for export to the poorest nations.
With the plethora of antitrust practices vying for action in Washington, D.C., law firms must strive to set themselves apart from the crowd. For attorneys at Wilmer Cutler Pickering Hale and Dorr LLP, that distinguishing characteristic is a collective tendency to think outside the box.
An inventor-congressman has introduced a bill in the U.S. House of Representatives that would speed up litigation and reduce costs by sending the lion’s share of patent cases to government-sanctioned “rocket docket” judges.
Two Canadian lumber-industry organizations are taking legal action in the United States to enforce a ruling under the North American Free Trade Agreement (NAFTA) that cleared Canada of unfairly subsidizing its softwood industry.
The European Union has responded coolly to an earlier warning by the United States that padding Airbus’ remodeling plan for its A350 aircraft with additional aid would exacerbate an already tense dispute before the World Trade Organization.
An administrative law judge overseeing integrated circuit provider Power Integrations Inc.’s patent infringement case against a Taiwanese rival has ruled in favor of the California company, moving the year-long U.S. International Trade Commission suit over power-supply controllers one step closer to a conclusion.
Fresh from defending its trademark in the U.K, Apple Computers will head back to court, this time to counter allegations that its iPod portable media devices infringe a patent held by Creative Technology Ltd.
Intellectual property boutique firm McAndrews Held & Malloy has come a long way from its humble beginnings. From a handful of partners and an office full of rented furniture, the firm has grown to an IP powerhouse that has taken on all the major firms in the country, and won.
USB key-drives have become ubiquitous enough to completely push floppy disks into the realm of the obsolete, but the patents involved are now under investigation by the U.S. International Trade Commission.
In a dispute that is turning into a complicated and expensive legal battle, the World Trade Organization set up a fourth panel on Tuesday to hear U.S. allegations that the airplane manufacturer Airbus is receiving illegal backing by European governments.
In a move signifying a boon for Amgen Inc. and a threat to the proposed sales of Hoffman-La Roche Inc.'s anti-anemia drug C.E.R.A. in the U.S., the U.S. International Trade Commission has initiated an investigation into whether the U.S. importation and sale of C.E.R.A. would violate Amgen’s patent rights.
With the advent of global health crises such as HIV/AIDS, global trading rules have been amended in recent years to provide poor countries with the right to break drug patents and produce cheap generic drugs.